Psyence Biomedical (PBM) Assets Average (2024 - 2025)
Psyence Biomedical (PBM) recorded quarterly Assets Average of $10.1 million in Q3 2025, up 110.31% quarter-over-quarter from $4.8 million in Q1 2025, and up 494.46% on a YoY basis from $1.7 million in Q3 2024.
Psyence Biomedical (PBM) Assets Average (2024 - 2025) Analysis & Trends
Psyence Biomedical's Assets Average history runs 2 years deep, the most recent figure standing at $10.1 million for Q3 2025.
- In Q3 2025, Assets Average rose 494.46% year-over-year to $10.1 million; the TTM figure through Sep 2025 stood at $10.1 million (up 494.46% YoY), while the FY2025 annual figure was $4.2 million, up 210.33% from the prior year.
- Assets Average was $10.1 million for Q3 2025 at Psyence Biomedical, up from $4.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $10.1 million in Q3 2025 to a low of $1.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 660.38 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 40.71 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.06 Mn |
| Mar 31, 2025 | 4.78 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.36 Mn |